News for Bristol Myers Squibb Co. - Google Finance

Reveal Insider Trading for Bristol-Myers Squibb, QUALCOMM, EMC, Freeport ...

Thu, 23 May 2013 12:56:06 GMT

Reveal Insider Trading for Bristol-Myers Squibb, QUALCOMM, EMC, Freeport ...
PR Newswire (press release) - 18 hours ago

Bristol-Myers Squibb Co. (NYSE: BMY): By the end of last trading session, the shares of Bristol Myers Squibb (NYSE: BMY) soared US$2.34 (or 5.31%) to US$46.40 with 25.35 million shares exchanged hands, compared to daily average volume of 10.39 ...

Bristol-Myers Shares Jump as Analyst Hails New Cancer Treatment Drug - 4-traders (press release)
Bristol Myers Squibb Upgraded to Buy by Citigroup (BMY) - The Utah People's Post

Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against ...

Mon, 20 May 2013 13:04:21 GMT

Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against ...
Insider Monkey (blog) - May 20, 2013

Sprycel: Developed by Bristol Myers Squibb Co. (NYSE:BMY), Sprycel was approved in 2006 as a second-line treatment for patients who had Philadelphia chromosome-positive (Ph+) ALL or Ph+ CML, and had resistance to prior therapy.

Bristol-Myers Squibb Company (BMY) Moves Higher Ahead of ASCO Presscast ...

Wed, 15 May 2013 14:55:13 GMT

Bristol-Myers Squibb Company (BMY) Moves Higher Ahead of ASCO Presscast ...
StreetInsider.com (subscription) - May 15, 2013

Shares of Bristol-Myers Squibb Company (NYSE: BMY) moved higher early on Wednesday. Abstracts for American Society of Clinical Oncology (ASCO) annual meeting are due to be released today at 6 pm, ahead of the meeting which begins on May 31st.

Bristol-Myers Squibb experimental melanoma drugs show early success - The Star-Ledger - NJ.com
Bristol-Myers shares surge on anticipated melanoma drug results - MarketWatch (blog)

News Buzz: Capstone Turbine Corporation, Walter Energy Inc, Bristol Myers ...

Wed, 22 May 2013 15:27:44 GMT

News Buzz: Capstone Turbine Corporation, Walter Energy Inc, Bristol Myers ...
Cogo - May 22, 2013

Capstone Turbine Corporation (NASDAQ:CPST) shares jumped 5.08% to $0.904. The company, on April 8, announced that it received an order for thirty-four liquid fuel C30s for use in DesignLine'sEco Saver IV range extended electric buses.

And The Best Bargain Is...Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY ...

Wed, 15 May 2013 19:46:42 GMT

And The Best Bargain Is...Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY ...
Insider Monkey (blog) - May 15, 2013

Bristol Myers Squibb Co. (NYSE:BMY) holds a market capitalization of $70 billion. For fiscal 2012, the company reported net sales that were 17% lower than the previous year.

BRISTOL MYERS SQUIBB CO. : EmergingGrowth.com looks at Small Cap ...

Tue, 14 May 2013 15:30:31 GMT

BRISTOL MYERS SQUIBB CO. : EmergingGrowth.com looks at Small Cap ...
4-traders (press release) - May 14, 2013

The company?s product portfolio includes Tridural, Abstral and Trelstar. In February of 2011, PLB acquired the Tempra line of products in Canada from Bristol-Myers Squibb (NYSE: BMY). In November of 2011, the company garnered the rights to Travelan in ...

BRISTOL MYERS SQUIBB CO. : Bristol-Myers Squibb to Present at Bank of ...

Wed, 08 May 2013 14:37:33 GMT

BRISTOL MYERS SQUIBB CO. : Bristol-Myers Squibb to Present at Bank of ...
4-traders (press release) - May 8, 2013

Bristol-Myers Squibb Company (NYSE: BMY) will present at Bank of America Merrill Lynch Health Care Conference on Wednesday, May 15, 2013, in Las Vegas.

The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, AbbVie ...

Tue, 07 May 2013 13:39:30 GMT

The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, AbbVie ...
Wall Street Journal (press release) - May 7, 2013

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bristol-Myers Squibb Company (NYSE:BMY), Sanofi (NYSE:SNY), AbbVie (NYSE:ABBV) ...

Bristol-Myers Squibb Profit Plunges On Patent Expiries Of Cardiovascular Drugs

Thu, 25 Apr 2013 13:25:22 GMT

Bristol-Myers Squibb Profit Plunges On Patent Expiries Of Cardiovascular Drugs
NASDAQ - Apr 25, 2013

(RTTNews.com) - Biopharmaceutical company Bristol-Myers Squibb Co. ( BMY ) Thursday reported a plunge in profit for the first quarter, as sales dropped 27 percent after U.S.

Bristol-Myers Squibb Co. (BMY) Reports In-Line Q1 EPS; Reaffirms - StreetInsider.com (subscription)
Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales - Fox Business

Bristol-Myers Squibb to Present at UBS Global Health Care Conference

Tue, 14 May 2013 19:26:30 GMT

Bristol-Myers Squibb to Present at UBS Global Health Care Conference
Wall Street Journal (press release) - May 14, 2013

Bristol-Myers Squibb Company (NYSE: BMY) will present at the UBS Global Health Care Conference on Tuesday, May 21, 2013, in New York City.